Correlation Between CVS Health and ReShape Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CVS Health and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVS Health and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CVS Health Corp and ReShape Lifesciences, you can compare the effects of market volatilities on CVS Health and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVS Health with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVS Health and ReShape Lifesciences.

Diversification Opportunities for CVS Health and ReShape Lifesciences

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between CVS and ReShape is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding CVS Health Corp and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and CVS Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVS Health Corp are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of CVS Health i.e., CVS Health and ReShape Lifesciences go up and down completely randomly.

Pair Corralation between CVS Health and ReShape Lifesciences

Considering the 90-day investment horizon CVS Health Corp is expected to generate 0.76 times more return on investment than ReShape Lifesciences. However, CVS Health Corp is 1.31 times less risky than ReShape Lifesciences. It trades about 0.05 of its potential returns per unit of risk. ReShape Lifesciences is currently generating about 0.01 per unit of risk. If you would invest  5,736  in CVS Health Corp on August 28, 2024 and sell it today you would earn a total of  165.00  from holding CVS Health Corp or generate 2.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CVS Health Corp  vs.  ReShape Lifesciences

 Performance 
       Timeline  
CVS Health Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CVS Health Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, CVS Health is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
ReShape Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

CVS Health and ReShape Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CVS Health and ReShape Lifesciences

The main advantage of trading using opposite CVS Health and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVS Health position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.
The idea behind CVS Health Corp and ReShape Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets